April 16, 2004
Efficiency means more than simply having all your documents in one place.
By Salvatore Salamone
Advances in identifying protein biomarkers are spurring new hope in cancer diagnostics, expediting detection and easing testing.
By Deborah Janssen
|Strategic Insights: Outsourcing and Contract Services
Custom software development needs flexibility.
By Kirk Gallion
Quality audits and quality agreements can help ensure success.
By Elizabeth Fowler and Carolyn Cardin
Choosing the right partner is key.
By Joel Hoffman
Conversation: Jason Barton
PalmOne's director of healthcare sales explains why clinical trials are driving sales of handheld devices.
Company to Watch
Serenex's chemoproteomic affinity platform could transform the drug discovery business.
Companies say fragment-based drug discovery is helping the business of lead identification.
Leveraging common standards across internal and external entities offers the greatest value proposition.
News & Analysis
Venter Makes Waves – Again
Clinical Standards Finally Start to Gel
FDA Vows to Fight Technology Barriers
Hard Disks Spin a Backup Alternative
Folkman Says Set Beliefs Inhibit Science
George Poste Calls for New IT Tools
First Base | Kevin Davies
Blackburn's dismissal is a black eye for bioethics.
Inside the Box | Bill Van Etten
Zeroconf enables auto-discovery of any local network.
Fully Equipped | Robert M. Frederickson
High-throughput protein separation methods evolve.
The Russell Transcript | John Russell
The FDA focuses on predictive development tools.